{"parse":{"title":"Pharmacocybernetics","pageid":37441392,"revid":831734857,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-style ambox-Orphan\" role=\"presentation\" style=\"display: none\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Wiki_letter_w.svg\" class=\"image\"><img alt=\"Wiki letter w.svg\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/6/6c/Wiki_letter_w.svg/40px-Wiki_letter_w.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/6/6c/Wiki_letter_w.svg/60px-Wiki_letter_w.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/6/6c/Wiki_letter_w.svg/80px-Wiki_letter_w.svg.png 2x\" data-file-width=\"44\" data-file-height=\"44\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>is an <a href=\"/wiki/Wikipedia:Orphan\" title=\"Wikipedia:Orphan\">orphan</a>, as no other articles <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Special:Whatlinkshere&amp;target=Pharmacocybernetics&amp;namespace=0\">link to it</a></b>. Please <a href=\"/wiki/Help:Link\" title=\"Help:Link\">introduce links</a> to this page from <span class=\"plainlinks\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Special%3ASearch&amp;redirs=1&amp;search=Pharmacocybernetics&amp;fulltext=Search&amp;ns0=1&amp;title=Special%3ASearch&amp;advanced=1&amp;fulltext=Pharmacocybernetics\">related articles</a></span>; try the <a rel=\"nofollow\" class=\"external text\" href=\"//edwardbetts.com/find_link?q=Pharmacocybernetics\">Find link tool</a> for suggestions.  <small><i>(September 2013)</i></small></div></td></tr></tbody></table>\n<p><b>Pharmacocybernetics</b> (also known as <b>pharma-cybernetics</b>, <b>cybernetic pharmacy</b> and <b>cyberpharmacy</b>) is an upcoming field that describes the science of supporting drugs and medications use through the application and evaluation of informatics and internet technologies, so as to improve the <a href=\"/wiki/Pharmaceutical_care\" title=\"Pharmaceutical care\">pharmaceutical care</a> of patients.<sup id=\"cite_ref-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture_1-0\" class=\"reference\"><a href=\"#cite_note-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture-1\">&#91;1&#93;</a></sup> It is an interdisciplinary field that integrates the domains of <a href=\"/wiki/Medicine\" title=\"Medicine\">medicine</a> and <a href=\"/wiki/Pharmacy\" title=\"Pharmacy\">pharmacy</a>, <a href=\"/wiki/Computer_science\" title=\"Computer science\">computer sciences</a> (informatics, cybernetics, interactive digital media, human-computer-environment interactions) and <a href=\"/wiki/Psychological_sciences\" class=\"mw-redirect\" title=\"Psychological sciences\">psychological sciences</a> to design, develop, apply and evaluate technological innovations which improve drugs and medications management, as well as prevent or solve drug-related problems.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Terminology\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Terminology</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Context\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Context</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Relation_to_pharmaceutical_care_and_drug-related_problems\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Relation to pharmaceutical care and drug-related problems</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Types_of_environments\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Types of environments</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Pharmacocybernetic_maxims\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Pharmacocybernetic maxims</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Terminology\">Terminology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacocybernetics&amp;action=edit&amp;section=1\" title=\"Edit section: Terminology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>\"Pharmaco\" originates from the Greek word \"pharmakon\", which means drugs or poisons;<sup id=\"cite_ref-Stedmans_Medical_Dictionary_2-0\" class=\"reference\"><a href=\"#cite_note-Stedmans_Medical_Dictionary-2\">&#91;2&#93;</a></sup> while \"<a href=\"/wiki/Cybernetics\" title=\"Cybernetics\">cybernetics</a>\" originates from the Greek word \"kubernetes\", which means \"the art of steering\".<sup id=\"cite_ref-Pangago_Getting_started_guide_to_cybernetics_3-0\" class=\"reference\"><a href=\"#cite_note-Pangago_Getting_started_guide_to_cybernetics-3\">&#91;3&#93;</a></sup> <a href=\"/wiki/Norbert_Wiener\" title=\"Norbert Wiener\">Norbert Wiener</a> first defined cybernetics as the science or study of \"control and communication in the animal and the machine\".<sup id=\"cite_ref-Pangago_Getting_started_guide_to_cybernetics_3-1\" class=\"reference\"><a href=\"#cite_note-Pangago_Getting_started_guide_to_cybernetics-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-ASC_Foundations_subject_of_cybernetics_4-0\" class=\"reference\"><a href=\"#cite_note-ASC_Foundations_subject_of_cybernetics-4\">&#91;4&#93;</a></sup> Since then, the <a href=\"/wiki/American_Society_for_Cybernetics\" title=\"American Society for Cybernetics\">American Society for Cybernetics</a> has further described this field as \"the design or discovery and application of principles of regulation and communication\".<sup id=\"cite_ref-ASC_Foundations_subject_of_cybernetics_4-1\" class=\"reference\"><a href=\"#cite_note-ASC_Foundations_subject_of_cybernetics-4\">&#91;4&#93;</a></sup>\n</p><p><a href=\"/wiki/Cybernetics\" title=\"Cybernetics\">Cybernetics</a> has been applied to many fields, such as <a href=\"/wiki/Anthropology\" title=\"Anthropology\">anthropology</a>, <a href=\"/wiki/Sociology\" title=\"Sociology\">sociology</a>, <a href=\"/wiki/System_theory\" class=\"mw-redirect\" title=\"System theory\">systems theory</a>, <a href=\"/wiki/Psychology\" title=\"Psychology\">psychology</a>, <a href=\"/wiki/Biology\" title=\"Biology\">biology</a>, <a href=\"/wiki/Computer_science\" title=\"Computer science\">computer science</a> and <a href=\"/wiki/Engineering\" title=\"Engineering\">engineering</a>. The defining characteristic of a cybernetic system is its relationship between endogenous goals and the external environment.<sup id=\"cite_ref-Corning_Synergy_cybernetics_and_evolution_of_politics_5-0\" class=\"reference\"><a href=\"#cite_note-Corning_Synergy_cybernetics_and_evolution_of_politics-5\">&#91;5&#93;</a></sup> In the 1970s, cybernetics was applied in healthcare as a means of setting positive outcome goals for patients who were not satisfied with their <a href=\"/wiki/Plastic_surgery\" title=\"Plastic surgery\">plastic surgeries</a>.<sup id=\"cite_ref-Psycho-cybernetics_author_6-0\" class=\"reference\"><a href=\"#cite_note-Psycho-cybernetics_author-6\">&#91;6&#93;</a></sup> The emergence of \"<a href=\"/wiki/New_cybernetics\" class=\"mw-redirect\" title=\"New cybernetics\">new cybernetics</a>\" or \"<a href=\"/wiki/Second-order_cybernetics\" title=\"Second-order cybernetics\">second-order cybernetics</a>\" further expanded this concept to include the interactions between cybernetic systems and the people interacting with them, as well as to society as a whole.<sup id=\"cite_ref-Geyer_Challenge_of_sociocybernetics_7-0\" class=\"reference\"><a href=\"#cite_note-Geyer_Challenge_of_sociocybernetics-7\">&#91;7&#93;</a></sup>\n</p><p>Cybernetics also includes the concept of \"<a href=\"/wiki/Cyberspace\" title=\"Cyberspace\">cyberspace</a>\", which is described by the science fiction author <a href=\"/wiki/William_Gibson\" title=\"William Gibson\">William Gibson</a> as a virtual representation of information in varying states of accessibility that is linked to various people and organizations in his book <a href=\"/wiki/Neuromancer\" title=\"Neuromancer\">Neuromancer</a>.<sup id=\"cite_ref-Adams_Cyberspace_and_virtual_places_8-0\" class=\"reference\"><a href=\"#cite_note-Adams_Cyberspace_and_virtual_places-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-Trappl_Cybernetics_and_systems_revival_9-0\" class=\"reference\"><a href=\"#cite_note-Trappl_Cybernetics_and_systems_revival-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-Gibson_Neuromancer_10-0\" class=\"reference\"><a href=\"#cite_note-Gibson_Neuromancer-10\">&#91;10&#93;</a></sup> This concept is also reiterated in the movie \"<a href=\"/wiki/The_Matrix\" title=\"The Matrix\">The Matrix</a>\" and its sequels, which revolves around <a href=\"/wiki/Neo_(The_Matrix)\" title=\"Neo (The Matrix)\">Neo</a> (<a href=\"/wiki/Keanu_Reeves\" title=\"Keanu Reeves\">Keanu Reeves</a>), a computer programmer, who lives in a simulated matrix world created by sentient machines but perceived by humans as reality. The term \"cyberspace\" is now used ubiquitously to describe anything that is associated with computers, informatics and internet technologies, and also user experiences through interactions with these technologies.\n</p>\n<h2><span class=\"mw-headline\" id=\"Context\">Context</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacocybernetics&amp;action=edit&amp;section=2\" title=\"Edit section: Context\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The increased popularity of informatics and internet technologies in healthcare has led to the development of various software, tools and applications for healthcare professionals and patients to improve pharmaceutical care and health-related outcomes. <a href=\"/wiki/Pharmacoinformatics\" title=\"Pharmacoinformatics\">Pharmacoinformatics</a> (or <a href=\"/wiki/Pharmacy_informatics\" class=\"mw-redirect\" title=\"Pharmacy informatics\">pharmacy informatics</a>) is a field within <a href=\"/wiki/Ehealth\" class=\"mw-redirect\" title=\"Ehealth\">e-health</a> that targets drug-related problems through the use of informatics and internet technologies.<sup id=\"cite_ref-Yap_Improving_pharmaceutical_care_in_oncology_by_pharmacoinformatics_11-0\" class=\"reference\"><a href=\"#cite_note-Yap_Improving_pharmaceutical_care_in_oncology_by_pharmacoinformatics-11\">&#91;11&#93;</a></sup> Pharmacocybernetics goes one step further by merging the science of technology with human-computer-environment interactions, so that technological innovations can be designed, developed, applied and evaluated in relation to supporting medicines and drugs use, as well as to reduce or prevent drug-related problems. Pharmacocybernetic approaches target patient care and safety, and they take into account the flow of information and knowledge between users and cybernetic systems or the environment, the actions taken by users to achieve their goals, user interactivity, as well as feedback.<sup id=\"cite_ref-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture_1-1\" class=\"reference\"><a href=\"#cite_note-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture-1\">&#91;1&#93;</a></sup> This field requires clinical knowledge and experience, as well as advanced skills and expertise to deal with technologies and human-computer-environment interactions in relation to the management of medicines and drug therapies.<sup id=\"cite_ref-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture_1-2\" class=\"reference\"><a href=\"#cite_note-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture-1\">&#91;1&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Relation_to_pharmaceutical_care_and_drug-related_problems\">Relation to pharmaceutical care and drug-related problems</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacocybernetics&amp;action=edit&amp;section=3\" title=\"Edit section: Relation to pharmaceutical care and drug-related problems\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><a href=\"/wiki/Pharmaceutical_care\" title=\"Pharmaceutical care\">Pharmaceutical care</a> involves the identification, solving and prevention of medication/drug-related problems with regards to patients' drug therapies.<sup id=\"cite_ref-ASHP_statement_on_pharmaceutical_care_12-0\" class=\"reference\"><a href=\"#cite_note-ASHP_statement_on_pharmaceutical_care-12\">&#91;12&#93;</a></sup> These problems are classified into various categories, which differ slightly between the American and European systems.\n</p><p>The <a href=\"/wiki/American_Society_of_Health-System_Pharmacists\" title=\"American Society of Health-System Pharmacists\">American Society of Health-System Pharmacists</a> classifies drug-related problems into eight major categories:<sup id=\"cite_ref-ASHP_statement_on_pharmaceutical_care_12-1\" class=\"reference\"><a href=\"#cite_note-ASHP_statement_on_pharmaceutical_care-12\">&#91;12&#93;</a></sup>\n</p>\n<ul><li>Untreated indications</li>\n<li>Medication use without indication</li>\n<li>Failure to receive medications</li>\n<li>Improper drug selections</li>\n<li>Underdose</li>\n<li>Overdose</li>\n<li>Adverse drug reactions</li>\n<li>Drug interactions</li></ul>\n<p>The Pharmaceutical Care Network Europe classifies them by problems and causes:<sup id=\"cite_ref-PCNE_classification_for_DRPs_v6.2_13-0\" class=\"reference\"><a href=\"#cite_note-PCNE_classification_for_DRPs_v6.2-13\">&#91;13&#93;</a></sup>\n</p><p><i>Classification by problems</i>:\n</p>\n<ul><li>Treatment effectiveness</li>\n<li>Adverse reactions</li>\n<li>Treatment costs</li>\n<li>Other types of problems</li></ul>\n<p><i>Classification by causes</i>:\n</p>\n<ul><li>Drug selection</li>\n<li>Drug form</li>\n<li>Dose selection</li>\n<li>Treatment duration</li>\n<li>Drug use/administration process</li>\n<li>Logistics-related</li>\n<li>Patient-related</li>\n<li>Other causes</li></ul>\n<p>The rapid adoption of <a href=\"/wiki/Cybermedicine\" class=\"mw-redirect\" title=\"Cybermedicine\">cybermedicine</a> has led to several other associated medication/drug-related problems.<sup id=\"cite_ref-Yap_Improving_pharmaceutical_care_in_oncology_by_pharmacoinformatics_11-1\" class=\"reference\"><a href=\"#cite_note-Yap_Improving_pharmaceutical_care_in_oncology_by_pharmacoinformatics-11\">&#91;11&#93;</a></sup> These include:\n</p>\n<ul><li>Digital dehumanization of the patient-practitioner relationship</li>\n<li>Virtual conflicts of recommendation</li>\n<li>Phenomenon of online self-prescribing</li></ul>\n<p>Pharmacocybernetics approaches target the whole <a href=\"/wiki/Digital_healthcare\" class=\"mw-redirect\" title=\"Digital healthcare\">digital healthcare</a> innovation cycle from identifying the healthcare problem, designing, developing, applying and evaluating the technological innovations that aim to address these drug-related problems. These technological innovations tend to be based on <a href=\"/wiki/User-centered_design\" title=\"User-centered design\">user-centered</a>, <a href=\"/wiki/User_experience_design\" title=\"User experience design\">experience-centered</a> and <a href=\"/wiki/Activity-centered_design\" title=\"Activity-centered design\">activity-centered</a> designs.\n</p>\n<h2><span class=\"mw-headline\" id=\"Types_of_environments\">Types of environments</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacocybernetics&amp;action=edit&amp;section=4\" title=\"Edit section: Types of environments\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The types of environments that are relevant to pharmacocybernetics approaches follow <a href=\"/wiki/Urie_Bronfenbrenner\" title=\"Urie Bronfenbrenner\">Urie Bronfenbrenner\u2019s</a> <a href=\"/wiki/Ecological_Systems_Theory\" class=\"mw-redirect\" title=\"Ecological Systems Theory\">Ecological Systems Theory</a>.<sup id=\"cite_ref-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture_1-3\" class=\"reference\"><a href=\"#cite_note-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Paquette_Bronfenbrenners_ecological_systems_theory_14-0\" class=\"reference\"><a href=\"#cite_note-Paquette_Bronfenbrenners_ecological_systems_theory-14\">&#91;14&#93;</a></sup> These environments, when applied to healthcare (for example, when a patient with a chronic disease searches the internet for information regarding his drug therapy), are as follows:\n</p>\n<ul><li><i>Microsystem</i> (the patient\u2019s immediate environment): The physical characteristics of the desktop or laptop, mouse sensitivity, or hardware and software faults that the patient experiences when performing the task.</li>\n<li><i>Mesosystem</i> (the relation between the patient\u2019s immediate environments): Whether the patient carries out the task alone or in the company of others will affect his experiences, psychological state and behavior.</li>\n<li><i>Exosystem</i> (the external settings that indirectly affect but do not include the patient): When his family also understands his medical condition and drug therapy, they can provide encouragement and support which will prompt a sense of closeness experienced by the patient. This in turn may lead to improved medication compliance.</li>\n<li><i>Macrosystem</i> (cultural context of the patient): Sharing of his experiences with other similar patients on social networking channels may alleviate the stigma felt and positively influence and enhance the experiences of the patient.</li>\n<li><i>Chronosystem</i> (the time-space dimension over the patient\u2019s course of life): As the patient gains more moral support in time from others with similar experiences, he can better adapt to life and may be motivated to improve his lifestyle and keep healthy.</li></ul>\n<h2><span class=\"mw-headline\" id=\"Pharmacocybernetic_maxims\">Pharmacocybernetic maxims</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacocybernetics&amp;action=edit&amp;section=5\" title=\"Edit section: Pharmacocybernetic maxims\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Four pharmacocybernetic maxims have been defined for designers and developers of pharmaco-informatics tools and applications that provide information on medications and drug therapies.<sup id=\"cite_ref-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture_1-4\" class=\"reference\"><a href=\"#cite_note-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Yap_Merging_the_old_with_the_new_15-0\" class=\"reference\"><a href=\"#cite_note-Yap_Merging_the_old_with_the_new-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-Chan_Detection_and_management_of_oncology_drug_interactions_16-0\" class=\"reference\"><a href=\"#cite_note-Chan_Detection_and_management_of_oncology_drug_interactions-16\">&#91;16&#93;</a></sup> These design principles are in relation to:\n</p>\n<ol><li><i>Quality of drug information</i>: The quality of the drug information provided by the tool/application should be accurate and evidence based. Its content should follow that from appropriate sources, such as research articles, established drug databases and drug package information.</li>\n<li><i>Quantity of drug information</i>: The tool/application should provide adequate content regarding the medication or drug therapy so that its users have enough knowledge to minimize the likelihood of drug-related problems.</li>\n<li><i>Relation to target audiences</i>: The medication- or drug-related content provided by the tool/application should be relevant to its target audience and clarify their doubts.</li>\n<li><i>Manner of data presentation</i>: The information provided by the tool/application should be presented in a clear manner that avoids ambiguity and misinterpretation.</li></ol>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacocybernetics&amp;action=edit&amp;section=6\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Yap_Pharmaco-cybernetics_as_an_interactive_component_of_pharma-culture_1-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\">Yap KY, Chuang X, Lee AJM, Lee RZ, Lim L, Lim JJ, Nimesha R. Pharmaco-cybernetics as an interactive component of pharma-culture: empowering drug knowledge through user-, experience- and activity-centered designs. International Journal of Computer Science Issues 2009; 3: 1-13.</span>\n</li>\n<li id=\"cite_note-Stedmans_Medical_Dictionary-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Stedmans_Medical_Dictionary_2-0\">^</a></b></span> <span class=\"reference-text\">Stedman TL. Stedman's Medical Dictionary. 28th ed. Baltimore, Maryland: Lippincott Williams &amp; Wilkins; 2005.</span>\n</li>\n<li id=\"cite_note-Pangago_Getting_started_guide_to_cybernetics-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Pangago_Getting_started_guide_to_cybernetics_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Pangago_Getting_started_guide_to_cybernetics_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Pangaro P. \"Getting started\" guide to cybernetics. Available at: <a rel=\"nofollow\" class=\"external free\" href=\"http://pangaro.com/published/cyber-macmillan.html\">http://pangaro.com/published/cyber-macmillan.html</a>.</span>\n</li>\n<li id=\"cite_note-ASC_Foundations_subject_of_cybernetics-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ASC_Foundations_subject_of_cybernetics_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ASC_Foundations_subject_of_cybernetics_4-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">American Society for Cybernetics. Foundations - the subject of cybernetics: defining 'cybernetics'. Available at: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.asc-cybernetics.org/foundations/definitions.htm\">http://www.asc-cybernetics.org/foundations/definitions.htm</a>.</span>\n</li>\n<li id=\"cite_note-Corning_Synergy_cybernetics_and_evolution_of_politics-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Corning_Synergy_cybernetics_and_evolution_of_politics_5-0\">^</a></b></span> <span class=\"reference-text\">Corning PA. Synergy, cybernetics, and the evolution of politics. International Political Science Review 1996; 17(1): 91-119. <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1177/019251296017001006\">DOI: 10.1177/019251296017001006</a></span>\n</li>\n<li id=\"cite_note-Psycho-cybernetics_author-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Psycho-cybernetics_author_6-0\">^</a></b></span> <span class=\"reference-text\">'Psycho-cybernetics' Author. <a rel=\"nofollow\" class=\"external text\" href=\"https://pqasb.pqarchiver.com/latimes/access/643367622.html?dids=643367622:643367622&amp;FMT=ABS&amp;FMTS=ABS:AI&amp;type=historic&amp;date=Nov+2%2C+1973&amp;author=&amp;pub=Los+Angeles+Times+%281886-Current+File%29&amp;edition=&amp;startpage=B5&amp;desc=%27PSYCHO-CYBERNETICS%27+AUTHOR\">Plastic surgeon tries to heal 'inner scars'</a>. Los Angeles Times 1973, 2 November; Sect. Part 1-A: B5-1.</span>\n</li>\n<li id=\"cite_note-Geyer_Challenge_of_sociocybernetics-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Geyer_Challenge_of_sociocybernetics_7-0\">^</a></b></span> <span class=\"reference-text\">Geyer F. The challenge of sociocybernetics. Kybernetes: The International Journal of Systems &amp; Cybernetics 1995; 24(4): 6-32. <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1108/03684929510089321\">DOI: 10.1108/03684929510089321</a></span>\n</li>\n<li id=\"cite_note-Adams_Cyberspace_and_virtual_places-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Adams_Cyberspace_and_virtual_places_8-0\">^</a></b></span> <span class=\"reference-text\">Adams PC. Cyberspace and virtual places. Geographical Review 1997; 87(2): 155-171.</span>\n</li>\n<li id=\"cite_note-Trappl_Cybernetics_and_systems_revival-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Trappl_Cybernetics_and_systems_revival_9-0\">^</a></b></span> <span class=\"reference-text\">Trappl R. The cybernetics and systems revival: Paper presented at: 14th European Meeting on Cybernetics and Systems Research (EMCSR'98); 14\u201317 April 1998; University of Vienna, Austrian Society for Cybernetic Studies.</span>\n</li>\n<li id=\"cite_note-Gibson_Neuromancer-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Gibson_Neuromancer_10-0\">^</a></b></span> <span class=\"reference-text\">Gibson W. Neuromancer (Special 20th Anniversary Edition). Hardcover ed: Ace Books; 2004.</span>\n</li>\n<li id=\"cite_note-Yap_Improving_pharmaceutical_care_in_oncology_by_pharmacoinformatics-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Yap_Improving_pharmaceutical_care_in_oncology_by_pharmacoinformatics_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Yap_Improving_pharmaceutical_care_in_oncology_by_pharmacoinformatics_11-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Yap KY, Chan A, Chui WK. Improving pharmaceutical care in oncology by pharmacoinformatics: the evolving role of informatics and the internet for drug therapy. Lancet Oncology 2009; 10(10): 1011-1019. <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/S1470-2045(09)70104-4\">DOI: 10.1016/S1470-2045(09)70104-4</a> <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19796753\">19796753</a></span>\n</li>\n<li id=\"cite_note-ASHP_statement_on_pharmaceutical_care-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ASHP_statement_on_pharmaceutical_care_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ASHP_statement_on_pharmaceutical_care_12-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">American Society of Hospital Pharmacists. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ashp.org/doclibrary/bestpractices/orgstpharmcare.aspx\">ASHP statement on pharmaceutical care</a>. American Journal of Hospital Pharmacy 1993; 50: 1720-1723.</span>\n</li>\n<li id=\"cite_note-PCNE_classification_for_DRPs_v6.2-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PCNE_classification_for_DRPs_v6.2_13-0\">^</a></b></span> <span class=\"reference-text\">Pharmaceutical Care Network Europe. PCNE classification for drug-related problems v6.2. Available at: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.pcne.org/sig/drp/documents/PCNE%20classification%20V6-2.pdf\">http://www.pcne.org/sig/drp/documents/PCNE%20classification%20V6-2.pdf</a>.</span>\n</li>\n<li id=\"cite_note-Paquette_Bronfenbrenners_ecological_systems_theory-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Paquette_Bronfenbrenners_ecological_systems_theory_14-0\">^</a></b></span> <span class=\"reference-text\">Paquette D, Ryan J. Bronfenbrenner\u2019s Ecological Systems Theory. Available at: <cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20070928164029/http://pt3.nl.edu/paquetteryanwebquest.pdf\">\"Archived copy\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://pt3.nl.edu/paquetteryanwebquest.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2007-09-28<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-09-28</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fpt3.nl.edu%2Fpaquetteryanwebquest.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacocybernetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span>.</span>\n</li>\n<li id=\"cite_note-Yap_Merging_the_old_with_the_new-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Yap_Merging_the_old_with_the_new_15-0\">^</a></b></span> <span class=\"reference-text\">Yap KY, Lim KJ. Merging the old with the new: a cybermedicine marriage for oncology interactions with traditional herbal therapies and complementary medicines. Tang - International Journal of Genuine Traditional Medicine 2012; 2(2): e18. <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.5667/tang.2012.0004\">DOI: 10.5667/tang.2012.0004</a></span>\n</li>\n<li id=\"cite_note-Chan_Detection_and_management_of_oncology_drug_interactions-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Chan_Detection_and_management_of_oncology_drug_interactions_16-0\">^</a></b></span> <span class=\"reference-text\">Chan A, Yap KY. Detection and management of oncology drug interactions: Can we do better? Maturitas 2010; 65(3): 181-182. <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.maturitas.2009.12.001\">DOI: 10.1016/j.maturitas.2009.12.001</a> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.pubmed.com/20036470\">PMID 20036470</a></span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw2193\nCached time: 20180921152608\nCache expiry: 86400\nDynamic content: true\nCPU time usage: 0.164 seconds\nReal time usage: 0.200 seconds\nPreprocessor visited node count: 565/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 6423/2097152 bytes\nTemplate argument size: 281/2097152 bytes\nHighest expansion depth: 16/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 13942/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.045/10.000 seconds\nLua memory usage: 1.6 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  159.710      1 -total\n 49.44%   78.960      1 Template:Reflist\n 34.53%   55.144      1 Template:Orphan\n 25.80%   41.208      1 Template:Ambox\n 22.00%   35.131      1 Template:Cite_web\n 11.33%   18.093      1 Template:PMID\n  9.18%   14.657      1 Template:Catalog_lookup_link\n  3.07%    4.904      2 Template:Yesno-no\n  1.73%    2.757      2 Template:Yesno\n  1.46%    2.325      4 Template:Trim\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:37441392-0!canonical and timestamp 20180921152608 and revision id 831734857\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"Orphaned_articles_from_September_2013"},{"sortkey":"","hidden":"","*":"All_orphaned_articles"},{"sortkey":"","*":"Pharmacy"},{"sortkey":"","*":"Cybernetics"}],"links":[{"ns":14,"exists":"","*":"Category:Orphaned articles from September 2013"},{"ns":0,"exists":"","*":"Activity-centered design"},{"ns":0,"exists":"","*":"American Society for Cybernetics"},{"ns":0,"exists":"","*":"American Society of Health-System Pharmacists"},{"ns":0,"exists":"","*":"Anthropology"},{"ns":0,"exists":"","*":"Biology"},{"ns":0,"exists":"","*":"Computer science"},{"ns":0,"exists":"","*":"Cybermedicine"},{"ns":0,"exists":"","*":"Cybernetics"},{"ns":0,"exists":"","*":"Cyberspace"},{"ns":0,"exists":"","*":"Digital healthcare"},{"ns":0,"exists":"","*":"Ecological Systems Theory"},{"ns":0,"exists":"","*":"Ehealth"},{"ns":0,"exists":"","*":"Engineering"},{"ns":0,"exists":"","*":"Keanu Reeves"},{"ns":0,"exists":"","*":"Medicine"},{"ns":0,"exists":"","*":"Neo (The Matrix)"},{"ns":0,"exists":"","*":"Neuromancer"},{"ns":0,"exists":"","*":"New cybernetics"},{"ns":0,"exists":"","*":"Norbert Wiener"},{"ns":0,"exists":"","*":"Pharmaceutical care"},{"ns":0,"exists":"","*":"Pharmacoinformatics"},{"ns":0,"exists":"","*":"Pharmacy"},{"ns":0,"exists":"","*":"Pharmacy informatics"},{"ns":0,"exists":"","*":"Plastic surgery"},{"ns":0,"exists":"","*":"Psychological sciences"},{"ns":0,"exists":"","*":"Psychology"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Second-order cybernetics"},{"ns":0,"exists":"","*":"Sociology"},{"ns":0,"exists":"","*":"System theory"},{"ns":0,"exists":"","*":"The Matrix"},{"ns":0,"exists":"","*":"Urie Bronfenbrenner"},{"ns":0,"exists":"","*":"User-centered design"},{"ns":0,"exists":"","*":"User experience design"},{"ns":0,"exists":"","*":"William Gibson"},{"ns":4,"exists":"","*":"Wikipedia:Orphan"},{"ns":12,"exists":"","*":"Help:Link"}],"templates":[{"ns":10,"exists":"","*":"Template:Orphan"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Monthyear"},{"ns":10,"exists":"","*":"Template:Monthyear-1"},{"ns":10,"exists":"","*":"Template:PAGENAMEU"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:PMID"},{"ns":10,"exists":"","*":"Template:Catalog lookup link"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:Yesno-no"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Wiki_letter_w.svg"],"externallinks":["https://dx.doi.org/10.1177/019251296017001006","https://pqasb.pqarchiver.com/latimes/access/643367622.html?dids=643367622:643367622&FMT=ABS&FMTS=ABS:AI&type=historic&date=Nov+2,+1973&author=&pub=Los+Angeles+Times+(1886-Current+File)&edition=&startpage=B5&desc='PSYCHO-CYBERNETICS'+AUTHOR","https://dx.doi.org/10.1108/03684929510089321","https://dx.doi.org/10.1016/S1470-2045(09)70104-4","//www.ncbi.nlm.nih.gov/pubmed/19796753","http://www.ashp.org/doclibrary/bestpractices/orgstpharmcare.aspx","https://web.archive.org/web/20070928164029/http://pt3.nl.edu/paquetteryanwebquest.pdf","http://pt3.nl.edu/paquetteryanwebquest.pdf","https://dx.doi.org/10.5667/tang.2012.0004","https://dx.doi.org/10.1016/j.maturitas.2009.12.001","http://www.pubmed.com/20036470","http://pangaro.com/published/cyber-macmillan.html","http://www.asc-cybernetics.org/foundations/definitions.htm","http://www.pcne.org/sig/drp/documents/PCNE%20classification%20V6-2.pdf","//edwardbetts.com/find_link?q=Pharmacocybernetics"],"sections":[{"toclevel":1,"level":"2","line":"Terminology","number":"1","index":"1","fromtitle":"Pharmacocybernetics","byteoffset":1150,"anchor":"Terminology"},{"toclevel":1,"level":"2","line":"Context","number":"2","index":"2","fromtitle":"Pharmacocybernetics","byteoffset":5341,"anchor":"Context"},{"toclevel":1,"level":"2","line":"Relation to pharmaceutical care and drug-related problems","number":"3","index":"3","fromtitle":"Pharmacocybernetics","byteoffset":7173,"anchor":"Relation_to_pharmaceutical_care_and_drug-related_problems"},{"toclevel":1,"level":"2","line":"Types of environments","number":"4","index":"4","fromtitle":"Pharmacocybernetics","byteoffset":9551,"anchor":"Types_of_environments"},{"toclevel":1,"level":"2","line":"Pharmacocybernetic maxims","number":"5","index":"5","fromtitle":"Pharmacocybernetics","byteoffset":11666,"anchor":"Pharmacocybernetic_maxims"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"6","fromtitle":"Pharmacocybernetics","byteoffset":13559,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Pharmacocybernetics","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q7180777"}]}}